Integration of substance use interventions into reproductive healthcare

Contributors SM and DTZ contributed equally to conceptualizationconceptualisation, writing, and revising. CEM contributed to project supervision and revision. The guarantor is CEM.

Funding CEM discloses grant funding (K23DA053507) from the National Institute on Drug Abuse.

Competing interests None declared.

Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting or dissemination plans of this research.

Patient consent for publication Not applicable.

Ethics approval Not applicable.

Provenance and peer review Not commissioned; externally peer reviewed.

Open access This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See https://creativecommons.org/licenses/by-nc/4.0/.

ORCID iD

Suhanee Mitragotri https://orcid.org/0009-0007-7316-6879

References

[1] Long M, Frederiksen B, Ranji U, et al. Women's health care utilization and costs:findings from the 2020 kff women's health survey. KFF; 2021. Available: https://www.commonwealthfund.org/publications/fund-reports/2020/jul/transforming-primary-health-care-women-part-1-framework[Accessed 11 May 2025].

[2] Transforming primary health care for women - part 1: a framework for addressing gaps and barriers. The Commonwealth Fund; 2020. Available: https://www.commonwealthfund.org/publications/fund-reports/2020/jul/transforming-primary-health-care-women-part-1framework [Accessed 11 May 2025].

[3] Sugarman DE, Haidamus MA, McHugh RK, et al. Menstrual pain and substance use in women receiving inpatient treatment for substance use disorders. J Addict Med 2025; 19:628-30.

[4] Chiuve SE, Kilpatrick RD, Hornstein MD, et al. Chronic opioid use and complication risks in women with endometriosis: A cohort study in US administrative claims. Pharmacoepidemiol Drug Saf 2021; 30:787-96.

[5] Casale R, Atzeni F, Bazzichi L, et al. Pain in women: A perspective review on a relevant clinical issue that deserves prioritization. Pain Ther 2021; 10:287-314.

[6] Opioid use and opioid use disorder in pregnancy. The American College of Obstetricians and Gynecologists; 2017. Available: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy [Accessed 11 May 2025].

[7] Smid MC, Terplan M. What obstetrician-gynecologists should know about substance use disorders in the perinatal period. Obstet Gynecol 2022; 139:317-37.

[8] Martin CE, Thakkar B, Cox L, et al. Beyond opioid prescribing: Evaluation of a substance use disorder curriculum for OBGYN residents. PLoS One 2022; 17:e0274563.

[9] Mertens JR, Chi FW, Weisner CM, et al. Physician versus nonphysician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: the ADVISe cluster randomized controlled implementation trial. Addict Sci Clin Pract 2015; 10:26.

[10] P Martin M, Woodside SG, Lee C, et al. SBIRT training: how do social work students compare to medical learners? Soc Work Health Care 2021; 60:631-41.